Selvas Healthcare

208370 · KOSDAQ · ₩208370 · 셀바스헬스케어

₩2,250▼ ₩30 (1.32%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Valuation model · Discounted cash flow (DCF)

We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.

Fair value per share

₩2,039

vs the current price (₩2,250)

Enterprise value
₩33B
Equity value
₩52B
WACC
7.4%

Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.

Bear / Base / Bull

Bear
₩1,495
−33.5%
Base
₩2,039
−9.4%
Bull
₩2,994
+33.0%

Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.

Assumptions

Sign in to change the assumptions and see the results update. Sign in

Cycle options

Margin path

Every year uses the cycle-average margin (8.7%).

Revenue growth

  • 3.6%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (3.6% a year, annual reports), fading to 3% by year 5.

  • 3.5%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (3.6% a year, annual reports), fading to 3% by year 5.

  • 3.3%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (3.6% a year, annual reports), fading to 3% by year 5.

  • 3.2%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (3.6% a year, annual reports), fading to 3% by year 5.

  • 3%

    How much sales grow that year, compared with the year before.

    Default: the last 3 years' revenue growth (3.6% a year, annual reports), fading to 3% by year 5.

Business

  • 8.7%

    Operating profit as a share of revenue.

    Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.

  • 27.5%

    Share of operating profit paid as corporate tax.

    Default: Korea's top corporate tax rate (25%) plus 10% local income tax.

  • 1.9%

    The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).

    Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).

  • 2.4%

    Money spent on factories, equipment, software and other long-term assets (% of revenue).

    Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).

  • 40%

    Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.

    Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.

Discount rate

  • 2%

    How fast cash flows keep growing every year after year 5.

    Default: about Korea's long-run inflation plus real growth.

  • 4.11%

    Yield on Korea's 10-year government bond: the return with almost no risk.

    Default: Korea Treasury Bond 10-year yield on 2026-10-28.

  • 0.6

    How much the share moves when the market moves: 1 means just like the market.

    Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.26, adjusted toward 1 and kept between 0.6 and 2.0.

  • 5.5%

    The extra return investors want for owning shares instead of bonds.

    Default: a typical premium for Korean shares.

  • 5.61%

    The interest rate the company would pay to borrow.

    Default: the 10-year yield plus a 1.5% credit spread.

Starting point

Revenue (TTM to H1 2026)
₩32B
Net debt (borrowings and leases − cash and deposits)
−₩20B
Shares
25,740,564
Share price
₩2,250
Market cap
₩58B

TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.

Past years and projection

Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.

FY2023FY2024FY2025Year 1Year 2Year 3Year 4Year 5
Revenue₩30B₩32B₩31B₩33B₩34B₩35B₩36B₩37B
Growth7.7%6.3%−2.8%3.6%3.5%3.3%3.2%3.0%
EBIT₩3.3B₩3.3B−₩162M₩2.9B₩3B₩3.1B₩3.2B₩3.2B
EBIT margin11.2%10.3%−0.5%8.7%8.7%8.7%8.7%8.7%
After-tax EBIT₩2.4B₩2.4B−₩117M₩2.1B₩2.1B₩2.2B₩2.3B₩2.4B
+ Depreciation———₩624M₩646M₩667M₩688M₩709M
− Capital spending₩369M₩737M₩1.1B₩788M₩816M₩842M₩869M₩895M
− Working capital₩1.7B₩4.5B₩782M₩456M₩460M₩449M₩449M₩435M
Free cash flow———₩1.5B₩1.5B₩1.6B₩1.7B₩1.7B
Discount factor———0.9310.8670.8070.7510.700
Present value———₩1.4B₩1.3B₩1.3B₩1.2B₩1.2B

Terminal value ₩37B, worth ₩26B today: 80% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.

Cross-check: what the market has paid before

For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:

LowTypicalHigh
Price / book (book value ₩2,944 a share)Now 0.76×₩4,1431.41×₩5,9732.03×₩15,1765.15×
Price / earnings (last 12 months: ₩338 a share)Now 6.66×₩2,6197.75×₩12,03535.6×₩21,77464.4×

Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.

Sensitivity

Fair value per share as two inputs change; the middle is the current case.

WACC ↓ · Terminal growth →1.0%1.5%2.0%2.5%3.0%
6.4%₩2,163₩2,241₩2,336₩2,455₩2,608
6.9%₩2,040₩2,100₩2,172₩2,260₩2,370
7.4%₩1,936₩1,983₩2,039₩2,106₩2,187
7.9%₩1,847₩1,884₩1,928₩1,979₩2,041
8.4%₩1,770₩1,800₩1,835₩1,875₩1,922

Now (TTM)

Market cap
₩58B
Enterprise value
₩37B
P/E
6.7×
P/B
0.8×
P/S
1.8×
EV/EBITDA
—
Dividend yield
0.0%

Over time (at each year end)

20252024202320222021
Price₩5,810₩4,055₩6,830₩2,090₩3,000
Market cap₩150B₩104B₩176B₩54B₩77B
P/E38.5×33.1×34.0×20.3×31.2×
P/B2.1×1.6×2.9×1.6×2.8×
P/S4.9×3.3×5.9×1.9×2.7×
EV/EBITDA—————
Dividend yield0.0%————

Versus similar companies

CompanyP/EP/BP/SEV/EBITDADividend yield
Selvas Healthcare6.7×0.8×1.8×—0.0%
TSE29.1×6.4×5.4×—0.2%
Kctech21.7×3.3×4.0×16.7×0.5%
Classys12.8×3.2×4.8×10.0×3.7%
Park Systems69.3×4.7×8.3×—0.2%
DI42.0×5.8×2.6×—0.6%
LivsMed—6.7×21.5×—0.0%
Similar companies (median)29.1×5.3×5.1×13.4×0.3%

Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.

Also known as: Selvas Healthcare / 셀바스헬스케어 / 208370 / KRX:208370

Source: KRX statistical information